Skip to main content
Signal8

Klichinsky Michael

SEC insider (Form 3/4/5 filer). CIK 0001967221. Chief Scientific Officer at Carisma Therapeutics Inc. (CARM). 6 reported Form 4/5 transactions since Sep 2024; latest on Oct 7, 2025. Located in PHILADELPHIA, PA.

Companies Klichinsky Michael has filed insider reports for

  • Carisma Therapeutics Inc. (CARM): Officer, Chief Scientific Officer
Klichinsky Michael profile photo

Klichinsky Michael

CIK: 0001967221

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (66.7%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)1 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Carisma Therapeutics Inc. logo
CARM

Carisma Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Carisma Therapeutics Inc. logo
    CARM

    Carisma Therapeutics Inc.

    Oct 7, 2025
    Exercise
    Direct
    57K shares at avg. $0.11$6K
  • Carisma Therapeutics Inc. logo
    CARM

    Carisma Therapeutics Inc.

    Oct 7, 2025
    Sale
    Direct
    57K shares at avg. $0.25$14K
  • Carisma Therapeutics Inc. logo
    CARM

    Carisma Therapeutics Inc.

    Oct 3, 2025
    Sale
    Direct
    119.3K shares at avg. $0.26$31K
  • Carisma Therapeutics Inc. logo
    CARM

    Carisma Therapeutics Inc.

    Oct 2, 2025
    Sale
    Direct
    200K shares at avg. $0.25$51K
  • Carisma Therapeutics Inc. logo
    CARM

    Carisma Therapeutics Inc.

    Oct 1, 2025
    Sale
    Direct
    165K shares at avg. $0.26$42K
  • Carisma Therapeutics Inc. logo
    CARM

    Carisma Therapeutics Inc.

    Jan 28, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    221K shares-

1-6 of 6